| Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma LG Feun, YY Li, C Wu, M Wangpaichitr, PD Jones, SP Richman, ... Cancer 125 (20), 3603-3614, 2019 | 153 | 2019 |
| Interleukin-6 (IL-6) released by macrophages induces IL-6 secretion in the human colon cancer HT-29 cell line YY Li, LL Hsieh, RP Tang, SK Liao, KY Yeh Human immunology 70 (3), 151-158, 2009 | 92 | 2009 |
| Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer M Wangpaichitr, C Wu, YY Li, DJM Nguyen, H Kandemir, S Shah, S Chen, ... Oncotarget 8 (30), 49275, 2017 | 86 | 2017 |
| Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers YY Li, JWC Chang, WC Chou, CC Liaw, HM Wang, JS Huang, CH Wang, ... Lung cancer 59 (2), 180-191, 2008 | 75 | 2008 |
| Analysis of the effect of serum interleukin-6 (IL-6) and soluble IL-6 receptor levels on survival of patients with colorectal cancer KY Yeh, YY Li, LL Hsieh, CH Lu, WC Chou, CC Liaw, RP Tang, SK Liao Japanese journal of clinical oncology 40 (6), 580-587, 2010 | 71 | 2010 |
| Autophagic mechanism in anti-cancer immunity: its pros and cons for cancer therapy YY Li, LG Feun, A Thongkum, CH Tu, SM Chen, M Wangpaichitr, C Wu, ... International journal of molecular sciences 18 (6), 1297, 2017 | 43 | 2017 |
| Relationship of metabolic alterations and PD-L1 expression in cisplatin resistant lung cancer M Wangpaichitr, H Kandemir, YY Li, C Wu, DJM Nguyen, LG Feun, ... Cell & developmental biology 6 (2), 2017 | 43 | 2017 |
| Targeting the kynurenine pathway for the treatment of cisplatin-resistant lung cancer DJM Nguyen, G Theodoropoulos, YY Li, C Wu, W Sha, LG Feun, ... Molecular Cancer Research 18 (1), 105-117, 2020 | 42 | 2020 |
| Culture supernatants of different colon cancer cell lines induce specific phenotype switching and functional alteration of THP-1 cells TH Wu, YY Li, TL Wu, JWC Chang, WC Chou, LL Hsieh, JR Chen, KY Yeh Cellular immunology 290 (1), 107-115, 2014 | 42 | 2014 |
| Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin N Savaraj, C Wu, YY Li, M Wangpaichitr, M You, J Bomalaski, W He, ... Oncotarget 6 (8), 6295, 2015 | 41 | 2015 |
| Macrophage-derived interleukin-6 up-regulates MUC1, but down-regulates MUC2 expression in the human colon cancer HT-29 cell line YY Li, LL Hsieh, RP Tang, SK Liao, KY Yeh Cellular immunology 256 (1-2), 19-26, 2009 | 37 | 2009 |
| Bisphosphonate zoledronic acid enhances the inhibitory effects of gefitinib on EGFR-mutated non-small cell lung carcinoma cells JWC Chang, JJ Hsieh, YC Shen, KY Yeh, CH Wang, YY Li, T Hsu Cancer letters 278 (1), 17-26, 2009 | 32 | 2009 |
| The combination of arginine deprivation and 5-fluorouracil improves therapeutic efficacy in argininosuccinate synthetase negative hepatocellular carcinoma A Thongkum, C Wu, YY Li, M Wangpaichitr, P Navasumrit, V Parnlob, ... International journal of molecular sciences 18 (6), 1175, 2017 | 30 | 2017 |
| Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells SM Chen, YY Li, CHT Tu, N Salazar, YY Tseng, Tseng, SF Huang, ... PLOS ONE 11 (8), e0161299, 2016 | 25 | 2016 |
| The− 174 G/C polymorphism in interleukin-6 (IL-6) promoter region is associated with serum IL-6 and carcinoembryonic antigen levels in patients with colorectal cancers in Taiwan KY Yeh, YY Li, LL Hsieh, JR Chen, RP Tang Journal of clinical immunology 30, 53-59, 2010 | 23 | 2010 |
| BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma YY Li, C Wu, SM Chen, SS Shah, M Wangpaichitr, LG Feun, MT Kuo, ... Oncotarget 7 (14), 17665, 2016 | 22 | 2016 |
| Degradation of AMPK‐α1 sensitizes BRAF inhibitor‐resistant melanoma cells to arginine deprivation YY Li, C Wu, SS Shah, SM Chen, M Wangpaichitr, MT Kuo, LG Feun, ... Molecular oncology 11 (12), 1806-1825, 2017 | 20 | 2017 |
| Neutralization of interleukin (IL)-10 released by monocytes/macrophages enhances the up-regulatory effect of monocyte/macrophage-derived IL-6 on expressions of IL-6 and MUC1 … YY Li, JWC Chang, LL Hsieh, KY Yeh Cellular immunology 265 (2), 164-171, 2010 | 20 | 2010 |
| Collaboration between RSK-EphA2 and Gas6-Axl RTK signaling in arginine starvation response that confers resistance to EGFR inhibitors MT Kuo, Y Long, WB Tsai, YY Li, HHW Chen, LG Feun, N Savaraj Translational oncology 13 (2), 355-364, 2020 | 19 | 2020 |
| Nivolumab to pembrolizumab switch induced a durable melanoma response: A case report T Lepir, M Zaghouani, SP Roche, YY Li, M Suarez, MJ Irias, N Savaraj Medicine 98 (2), e13804, 2019 | 19 | 2019 |
